Continuous high-titer HIV-1 vector production

Nature Biotechnology

Volumn 21, Issue 5, 2003, Pages 569-572

  Ikeda, Yasuhiro ^a   Takeuchi, Yasuhiro ^a   Martin, Francisco ^a   Cosset, Francois Loic ^b   Mitrophanous, Kyriacos ^c   Collins, Mary ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITÉ DE LYON   (France)

^c OXFORD BIOMEDICA UK LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELLS; CLONING; PROTEINS;

PACKAGING CELLS;

VIRUSES;

ANTIGEN P24; GAG PROTEIN; POL PROTEIN; PROTEINASE; RETROVIRUS VECTOR;

ARTICLE; GENE TRANSFER; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURAL GENE; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS REPLICATION;

GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HELA CELLS; HIV-1; HUMANS; QUALITY CONTROL; TRANSFECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; MURINE LEUKEMIA VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0038333587     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt815     Document Type: Article

References (20)

1. Sparacio, S., Pfeiffer, T., Schaal, H. & Bosch, V. Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors. Mol. Ther. 3, 602-612 (2001).
2. Kaul, M., Yu, H., Ron, Y. & Dougherty, J.P. Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences. Virology 249, 167-174 (2001).
3. Klages, N., Zufferey, R. & Trono, D. A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol. Ther. 2, 170-t76 (2000).
4. Srinivasakumar, N. et al. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines. J. Virol. 71, 5841-5848 (1997).
5. Corbeau, P., Kraus, G. & Wong-Staal, F. Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line. Proc. Natl. Acad. Sci. USA 93, 14070-14075 (1996).
6. Carroll, R. et al. A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines. J. Virol. 68, 6047-6051 (1994).
7. Kaplan, A.H. & Swanstrom, R. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proc. Natl. Acad. Sci. USA 88, 4528-4532 (1991).
8. Hoxie, J.A., Haggarty, B.S., Rackowski, J.L., Pillsbury, N. & Levy, J.A. Persistent non-cytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus. Science 229, 1400-1402 (1985).
9. Ott, D.E., Nigida, S.M., Henderson, J.L.E. & Arthur, L.O. The majority of cells are superinfected in a cloned cell line that produces high levels of human immunodeficiency virus type 1 strain MN. J. Virol. 69, 2443-2450 (1995).
10. Kotsopoulo, E., Kim, V.N., Kingsman, A.J., Kingsman, S.M. & Mitrophanous, K.A. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV gag-pol gene. J. Virol. 74, 4839-4852 (2000).
11. Soneoka, Y. et al. A transient three-plasmid expression system for the production of high-titer retroviral vectors. Nucleic Acids Res. 23, 628-633 (1995).
12. Hacein-Bey-Abina, S. et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185-1193 (2002).
13. Kiem, H.P. et al. Gene transfer into marrow repopulating cells: comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood 90, 4638-4645 (1997).
14. Kelly, P.F., Vandergriff, J., Nathwani, A., Nienhuis, A.W. & Vanin, E.F. Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. Blood 96,1206-1214 (2000).
15. Cosset, F.-L., Takeuchi, Y., Battini, J.-L., Weiss, R.A. & Collins, M.K. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69, 7430-7436 (1995).
16. low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo. Hum. Gene Ther. 9, 1497-1511 (1998).
17. Demaison, C. et al. High-level transduction and gene expression in hematopoietic repopulation cells using a human immunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum. Gene Ther. 13, 803-813 (2002).
18. Schroder, A.R. et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521-529 (2002).
19. Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L. & Trono, D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15, 871-875 (1997).
20. Besnier, C., Takeuchi, Y. & Towers, G. Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. USA 99, 11920-11925 (2002).